Changes in tumor size by RECIST correlate with survival
(HealthDay) -- RECIST categories used to quantify tumor changes during exposure to anticancer therapies correlate well with overall survival (OS) but reflect a more linear continuum without clear inflection points, according ...
Jun 13, 2012
0
0